Many pharma and biotech companies are also focusing in on Trump’s proposal to allow U.S. pharmaceutical companies to repatriate foreign cash at a 10 percent tax rate (rather than the current 35 percent tax rate), which would potentially increase both profit and growth opportunities for the sector.
We are The People's Media. USA Herald covers everything from breaking news to investigative journalism. We also report on politics on the State and National levels.
